CFHR3 Gene - Complement Factor H Related 3

A key regulator of complement activation and associated with renal and ocular diseases

Gene Information Card

Symbol CFHR3
Full Name Complement Factor H Related 3
Gene Type Protein coding
Chromosomal Location 1q31.3
NCBI Gene ID 10878 ncbi.nlm.nih.gov/gene/10878
Ensembl ID ENSG00000116785
UniProt ID Q02985
OMIM ID 605336
HGNC ID 4883
Aliases CFHL3, FHR3, HLF4

Description

The CFHR3 gene encodes complement factor H-related protein 3 (FHR-3), a member of the complement factor H protein family. FHR-3 is a secreted glycoprotein that modulates the alternative pathway of complement activation by competing with factor H for binding to C3b and microbial surfaces. It plays a role in immune surveillance and inflammation. Genetic variations in CFHR3, including copy number variations and deletions, are associated with susceptibility to age-related macular degeneration (AMD), atypical hemolytic uremic syndrome (aHUS), and C3 glomerulopathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Age-related macular degeneration (AMD) CFHR3 deletion (delCFHR3-CFHR1) reduces complement regulation on retinal surfaces, increasing inflammation and drusen formation PMID: 17053108, 20385826
Atypical hemolytic uremic syndrome (aHUS) CFHR3 mutations or hybrid genes disrupt complement control on endothelial cells, leading to microvascular thrombosis PMID: 17634419, 23307826
C3 glomerulopathy CFHR3 gene rearrangements (e.g., CFHR3-CFHR1 fusion) cause uncontrolled complement activation and C3 deposition in glomeruli PMID: 22549409, 24029273
IgA nephropathy CFHR3 deletion influences complement activation and disease progression PMID: 21849964

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Plasma N/A Secreted
Kidney 3.2 Low
Retina 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 14.0 Hepatocyte cell line
ARPE-19 2.5 Retinal pigment epithelial cells
HK-2 1.0 Kidney proximal tubule cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
delCFHR3-CFHR1 Deletion Common (allele frequency ~0.15 in Europeans) Loss of CFHR3 and CFHR1; associated with reduced AMD risk but increased aHUS risk
c.481C>T (p.Arg161*) Nonsense Rare Premature stop; loss of function; linked to aHUS
c.824G>A (p.Arg275Gln) Missense Rare Altered C3b binding; potential gain-of-function in complement regulation
Mutation functional classification

Loss of Function (LOF)

Deletion of CFHR3 (delCFHR3-CFHR1) leads to loss of FHR-3 protein, reducing competition with factor H and increasing complement activation on surfaces.

Gain of Function (GOF)

Missense mutations like p.Arg275Gln may enhance C3b binding, leading to excessive complement inhibition and immune evasion.

Dominant Negative (DN)

Hybrid genes (e.g., CFHR3-CFHR1) produce aberrant proteins that interfere with normal factor H and FHR function, causing dysregulated complement.

Pathways

Complement and coagulation cascades (KEGG: hsa04610)
Alternative complement pathway (Reactome: R-HSA-173736)

Protein Summary

Complement factor H-related protein 3 (FHR-3) is a 42 kDa secreted glycoprotein composed of five short consensus repeat (SCR) domains. It shares high sequence homology with complement factor H (CFH) but lacks the C-terminal regulatory domains. FHR-3 binds to C3b and microbial surfaces, competing with CFH and modulating complement activation. It is primarily produced in the liver and circulates in plasma. FHR-3 plays a role in immune evasion of pathogens and is implicated in complement-mediated diseases.

Related Products

Product name Cat.No. Species Gene ID
CFHR3 Knockout HEK293 Cell Line EDJ-KQ51013 Human 10878 Details Get a Quote
CFHR3 Knockout HeLa Cell Line EDJ-KQ55510 Human 10878 Details Get a Quote
CFHR3 Knockout A-549 Cell Line EDJ-KQ64000 Human 10878 Details Get a Quote
CFHR3 Knockout HCT 116 Cell Line EDJ-KQ72451 Human 10878 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: